CoChat
Cited by 45

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

cAMP signaling in cortisol-producing adrenal adenoma

Calebiro, Davide, Di Dalmazi, Guido, Bathon, Kerstin, Ronchi, Cristina L, Beuschlein, Felix · 2015 · European Journal of Endocrinology

Abstract

The cAMP signaling pathway is one of the major players in the regulation of growth and hormonal secretion in adrenocortical cells. Although its role in the pathogenesis of adrenocortical hyperplasia associated with Cushing's syndrome has been clarified, a clear involvement of the cAMP signaling pathway and of one of its major downstream effectors, the protein kinase A (PKA), in sporadic adrenocortical adenomas remained elusive until recently. During the last year, a report by our group and three additional independent groups showed that somatic mutations of PRKACA, the gene coding for the catalytic subunit α of PKA, are a common genetic alteration in patients with Cushing's syndrome due to adrenal adenomas, occurring in 35–65% of the patients.In vitro studies revealed that those mutations are able to disrupt the association between catalytic and regulatory subunits of PKA, leading to a cAMP-independent activity of the enzyme. Despite somatic PRKACA mutations being a common finding in patients with clinically manifest Cushing's syndrome, the pathogenesis of adrenocortical adenomas associated with subclinical hypercortisolism seems to rely on a different molecular background. In this review, the role of cAMP/PKA signaling in the regulation of adrenocortical cell function and its alterations in cortisol-producing adrenocortical adenomas will be summarized, with particular focus on recent developments.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1530/eje-15-0353

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 38

  1. 10.1210/en.2004-0900 · DOI · Paper page
  2. 10.1111/j.1749-6632.2002.tb04327.x · DOI · Paper page
  3. Perez-Nanclares G Velayos T Vela A Muñoz-Torres M Castaño L . Pseudohypoparathyroidism type Ib associated with novel duplications in the GNAS locus. PLoS ONE 2015 10 e0117691. (doi:10.1371/journal.pone.0117691). · doi:10.1371/journal.pone.0117691
  4. 10.1016/j.mce.2010.01.008 · DOI
  5. 10.1038/ncpendmet0324 · DOI
  6. Vassart G Costagliola S . G protein-coupled receptors: mutations and endocrine diseases. Nature Reviews. Endocrinology 2011 7 362–372. (doi:10.1038/nrendo.2011.20). · DOI · Paper page
  7. 10.1038/nrc3521 · DOI · Paper page
  8. 10.1056/NEJMoa1310359 · DOI · Paper page
  9. 10.1038/ng.2956 · DOI · Paper page
  10. 10.1159/000134829 · DOI
  11. Magiakou MA Smyrnaki P Chrousos GP . Hypertension in Cushing's syndrome. Best Practice & Research. Clinical Endocrinology & Metabolism 2006 20 467–482. (doi:10.1016/j.beem.2006.07.006). · DOI
  12. Zacharieva S Orbetzova M Stoynev A Shigarminova R Yaneva M Kalinov K Nachev E Elenkova A . Circadian blood pressure profile in patients with Cushing's syndrome before and after treatment. Journal of Endocrinological Investigation 2004 27 924–930. (doi:10.1007/BF03347534). · doi:10.1007/bf03347534
  13. 10.1159/000314349 · DOI
  14. 10.1210/jc.86.1.117 · DOI · Paper page
  15. Arnaldi G Mancini T Tirabassi G Trementino L Boscaro M . Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications. Journal of Endocrinological Investigation 2012 35 434–448. (doi:10.1007/BF03345431). · DOI
  16. 10.1016/0002-9343(52)90027-2 · DOI · Paper page
  17. Colao A Cozzolino A Pivonello R . Quality of life in patients with Cushing's disease: a modern approach. Clinical Endocrinology 2012 76 776–777. (doi:10.1111/j.1365-2265.2012.04344.x). · DOI
  18. 10.1111/j.1365-2265.2008.03310.x · DOI
  19. 10.1210/jc.2009-0468 · DOI · Paper page
  20. 10.1002/jbmr.398 · DOI · Paper page
  21. 10.1530/EJE-11-1039 · DOI · Paper page
  22. Di Dalmazi G Vicennati V Garelli S Casadio E Rinaldi E Giampalma E Mosconi C Golfieri R Paccapelo A Pagotto U . Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study. Lancet. Diabetes & Endocrinology 2014 2 396–405. (doi:10.1016/S2213-8587(13)70211-0). · DOI · Paper page
  23. 10.1111/j.1749-6632.2002.tb04326.x · DOI
  24. 10.1038/nrm3432 · DOI · Paper page
  25. 10.1074/jbc.M110.155150 · DOI
  26. Taskén K Skålhegg BS Solberg R Andersson KB Taylor SS Lea T Blomhoff HK Jahnsen T Hansson V . Novel isozymes of cAMP-dependent protein kinase exist in human cells due to formation of RIα-RIβ heterodimeric complexes. Journal of Biological Chemistry 1993 268 21276–21283. · DOI
  27. 10.1126/science.1104607 · DOI · Paper page
  28. 10.1002/jemt.10337 · DOI · Paper page
  29. 10.1677/jme.0.0290163 · DOI
  30. 10.1016/j.mce.2010.11.018 · DOI
  31. 10.1056/NEJM199112123252403 · DOI · Paper page
  32. 10.1038/ncpendmet0321 · DOI
  33. 10.1210/jc.2008-2333 · DOI · Paper page
  34. 10.1158/0008-5472.CAN-06-2914 · DOI
  35. 10.1124/mol.110.069104 · DOI
  36. Calebiro D Hannawacker A Lyga S Bathon K Zabel U Ronchi C Beuschlein F Reincke M Lorenz K Allolio B . PKA catalytic subunit mutations in adrenocortical Cushing's adenoma impair association with the regulatory subunit. Nature Communications 2014 5 5680. (doi:10.1038/ncomms6680). · DOI · Paper page
  37. 10.1073/pnas.1424206112 · DOI · Paper page
  38. 10.1530/EJE-08-0299 · DOI

Cited by

See all 45

Metadata

Authors
Calebiro, D., Di Dalmazi, G., Bathon, K., Ronchi, C. L., & Beuschlein, F.
Venue
European Journal of Endocrinology
Published
2015-10
Volume
173
Issue
4
Pages
M99-M106
ISSN
  • 0804-4643
  • 1479-683X
Cited by
45
References
19

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.